PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34520240-0	2021	Retraction of: miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1 (doi: 10.1089/cbr.2018.2749).	Doxorubicin	33-43	microRNA 132	Homo sapiens	15-22	
32505695-0	2020	Doxorubicin induces cytotoxicity and miR-132 expression in granulosa cells.	Doxorubicin	0-11	microRNA 132	Homo sapiens	37-44	
32505695-11	2020	Altogether, these findings contribute to understanding the hormonal disbalance caused by DOX in human ovarian cells and suggest miR-132 as a putative sensor to predict DOX-induced ovarian toxicity.	Doxorubicin	168-171	microRNA 132	Homo sapiens	128-135	
30939040-0	2019	miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1.	Doxorubicin	18-28	microRNA 132	Homo sapiens	0-7	
30939040-5	2019	This study investigated the role of miR-132 in regulating ERK1 expression and affecting CRC cell proliferation, apoptosis, and adriamycin (ADM) resistance.	Doxorubicin	127-137	microRNA 132	Homo sapiens	36-43	
30939040-5	2019	This study investigated the role of miR-132 in regulating ERK1 expression and affecting CRC cell proliferation, apoptosis, and adriamycin (ADM) resistance.	Doxorubicin	139-142	microRNA 132	Homo sapiens	36-43	
30939040-13	2019	Conclusions: miR-132 reduction and ERK1 elevation are related to ADM resistance in CRC cells.	Doxorubicin	65-68	microRNA 132	Homo sapiens	13-20	
30939040-14	2019	Upregulation of miR-132 expression inhibits CRC cell proliferation, induces apoptosis, and reduces ADM resistance possibly by targeting ERK1 expression.	Doxorubicin	99-102	microRNA 132	Homo sapiens	16-23	
30024792-10	2019	In addition, miR132-3p+ significantly increased the delivery of doxorubicin across the BTB in vitro and contributed to the accumulation of doxorubicin within the brain tumor tissue.	Doxorubicin	64-75	microRNA 132	Homo sapiens	13-19	
30024792-10	2019	In addition, miR132-3p+ significantly increased the delivery of doxorubicin across the BTB in vitro and contributed to the accumulation of doxorubicin within the brain tumor tissue.	Doxorubicin	139-150	microRNA 132	Homo sapiens	13-19	
29567542-4	2018	Quantitative real-time PCR (qRT-PCR) was used to quantify the expression of miR-132/-212 (miR-132 and miR-212) in doxorubicin (DOX)-resistant and -sensitive breast cancer tumors and cells.	Doxorubicin	114-125	microRNA 132	Homo sapiens	76-83	
29567542-4	2018	Quantitative real-time PCR (qRT-PCR) was used to quantify the expression of miR-132/-212 (miR-132 and miR-212) in doxorubicin (DOX)-resistant and -sensitive breast cancer tumors and cells.	Doxorubicin	114-125	microRNA 132	Homo sapiens	90-97	
29567542-4	2018	Quantitative real-time PCR (qRT-PCR) was used to quantify the expression of miR-132/-212 (miR-132 and miR-212) in doxorubicin (DOX)-resistant and -sensitive breast cancer tumors and cells.	Doxorubicin	127-130	microRNA 132	Homo sapiens	76-83	
29567542-4	2018	Quantitative real-time PCR (qRT-PCR) was used to quantify the expression of miR-132/-212 (miR-132 and miR-212) in doxorubicin (DOX)-resistant and -sensitive breast cancer tumors and cells.	Doxorubicin	127-130	microRNA 132	Homo sapiens	90-97	
29567542-6	2018	We found that miR-132/-212 were commonly overexpressed in DOX-resistant breast cancer tumors and cells.	Doxorubicin	58-61	microRNA 132	Homo sapiens	14-21	
29567542-7	2018	Silenced miR-132/-212 expression induced DOX accumulation in MCF-7/ADR cells, while overexpression of miR-132/-212 led to breast cancer resistance protein (BCRP)-based DOX efflux in MCF-7 cells.	Doxorubicin	41-44	microRNA 132	Homo sapiens	9-16	
29567542-7	2018	Silenced miR-132/-212 expression induced DOX accumulation in MCF-7/ADR cells, while overexpression of miR-132/-212 led to breast cancer resistance protein (BCRP)-based DOX efflux in MCF-7 cells.	Doxorubicin	168-171	microRNA 132	Homo sapiens	9-16	
29567542-7	2018	Silenced miR-132/-212 expression induced DOX accumulation in MCF-7/ADR cells, while overexpression of miR-132/-212 led to breast cancer resistance protein (BCRP)-based DOX efflux in MCF-7 cells.	Doxorubicin	168-171	microRNA 132	Homo sapiens	102-109	
29567542-9	2018	Down-regulation of miR-132/-212 sensitized MCF-7/ADR cells to DOX.	Doxorubicin	62-65	microRNA 132	Homo sapiens	19-26